IP Library Granted Patent US 8,003,809
Granted Patent B2
US 8,003,809 · App. 12/390,000 · Granted Aug 23, 2011

Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,003,809
App. No.
12/390,000
Granted
Aug 23, 2011
Kind
B2
Abstract

Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

Claims (41)

1. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of formula (XI) or a salt thereof, comprising contacting a compound of Formula (I) or a salt thereof with gabapentin or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is methyl;

R 3 is hydrogen; and

R 5 and R 6 are each hydrogen.

2. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of Formula (XII) or a salt thereof, comprising contacting a compound of Formula (I) or a salt thereof with baclofen or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is isopropyl;

R 3 is hydrogen; and

R 5 and R 6 are each hydrogen.

3. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of Formula (XIII) or salt thereof comprising contacting a compound of Formula (I) or salt thereof with R-(−)-baclofen or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is isopropyl;

R 3 is hydrogen; and

R 5 and R 6 are each hydrogen.

4. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of the formula:

or salt thereof comprising contacting a compound of Formula (I) or salt thereof with tranexamic acid or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is methyl;

R 3 is hydrogen; and

R 5 and R 6 are each hydrogen.

5. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of the formula:

or salt thereof comprising contacting a compound of Formula (I) or salt thereof with pregabalin or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is methyl;

R 3 is hydrogen; and

R 5 and R 6 are each hydrogen.

6. A compound of Formula (I) or a salt thereof;

wherein:

R 1 is isopropyl;

R 2 is selected from methyl and isopropyl;

R 3 is hydrogen; and

R 5 and R 6 are each hydrogen, acylamino, acyloxy, alkoxycarbonylamino, alkoxycarbonyloxy, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, arylalkyl, carbamoyloxy, dialkylamino, heteroaryl, hydroxy, sulfonamido, or optionally, R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl, substituted cycloheteroalkyl, or substituted aryl ring.

7. The compound of claim 6 , wherein R 5 and R 6 are each hydrogen.

8. The compound of claim 6 , wherein the stereochemistry of the carbon to which R 2 and R 3 are attached is of the S-onfiguration.

9. The compound of claim 6 , wherein the stereochemistry of the carbon to which R 2 and R 3 are attached is of the R-configuration.

Assignments (8)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
SECURITY INTEREST Recorded Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2009
From: GALLOP, MARK A.; SCHEUERMAN, RANDALL A.; DAI, XUEDONG; RAILLARD, STEPHEN P.; MANTHATI, SURESH K.; YAO, FENMEI; LUDWIKOW, MARIA; PHAN, THU; PENG, GE; BHAT, SEEMA
To: XENOPORT, INC.
Reel/Frame 022546/0088 →